The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Abstract Microglial activation is a central player in the pathophysiology of Alzheimer’s disease (AD). The soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) can serve as a marker for microglial activation and has been shown to be overexpressed in AD. However, the relation...
Main Authors: | So-Hee Park, Eun-Hye Lee, Hyung-Ji Kim, Sungyang Jo, Sunju Lee, Sang Won Seo, Hyun-Hee Park, Seong-Ho Koh, Jae-Hong Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92101-6 |
Similar Items
-
Does Soluble TREM2 Protect Against Alzheimer's Disease?
by: Guy C. Brown, et al.
Published: (2022-01-01) -
TREM2 ectodomain and its soluble form in Alzheimer’s disease
by: Jiaolong Yang, et al.
Published: (2020-07-01) -
Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01) -
Association between Cerebrospinal Fluid Soluble <i>TREM2</i>, Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Wenchuan Zhou, et al.
Published: (2023-05-01) -
The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
by: Li Zhong, et al.
Published: (2019-11-01)